Network origin in Jeanine Clemente first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 33 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jeanine Clemente via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Investment Banks/Brokers | Analyst-Equity | |
JPMorgan Investment Management, Inc.
JPMorgan Investment Management, Inc. Investment ManagersFinance JPMorgan Investment Management, Inc. (JPMIM) is a global, SEC-registered investment advisor headquartered in New York City. The firm was founded in 2000 as the result of Chase Manhattan's purchase of Robert Fleming Holdings and the subsequent merger of Chase and JPMorgan. In January 2010, JPMorgan Investment Advisors merged into JP Morgan Investment Management. JPMIM is a subsidiary of JPMorgan Asset Management Holdings, Inc., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM). The firm primarily provides investment advisory services to both US and non-US institutional and retail clients. | Investment Managers | Analyst-Equity | |
PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Priority Healthcare Corp.
Priority Healthcare Corp. Medical DistributorsDistribution Services Priority Healthcare Corp. distributes pharmaceuticals and related medical products. The company provides biopharmaceuticals, medical, and complementary support services tailored to the individual needs of the customers and patients. The company offers its services in different parts of United States. The company was founded by William E. Bindley on June 23, 1994 and is headquartered in Lake Mary, FL. | Medical Distributors | Director/Board Member | |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Investment Banks/Brokers | Analyst-Equity | |
Cantor Fitzgerald & Co.
Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Cantor Fitzgerald & Co. is the investment bank and brokerage subsidiary of CFS CF & Co. I Holdings LP, which is owned by Cantor Fitzgerald LP in the US. The firm was founded by Bernie Gerald Cantor and John Fitzgerald in 1945. Headquartered in New York City, Cantor Fitzgerald offers clients a global, multi-asset prime brokerage platform with a focus on the quality middle market. | Investment Banks/Brokers | Director of Research - Equity | |
FENNEC PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
GENTIUM S.P.A. (ADR) | Pharmaceuticals: Major | Corporate Officer/Principal | |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Sales & Marketing | |
Agilis Biotherapeutics LLC
Agilis Biotherapeutics LLC BiotechnologyHealth Technology Agilis Biotherapeutics LLC operates as a biotechnology company. It focuses on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are no or limited treatment options. The company was founded in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Clarkson University | College/University | Undergraduate Degree | |
Yale University | College/University | Doctorate Degree Doctorate Degree | |
University of Illinois | College/University | Doctorate Degree | |
Terumo Medical Corp.
Terumo Medical Corp. Medical SpecialtiesHealth Technology Terumo Medical Corp. manufactures and distributes medical products. It offers products through three business divisions: Terumo Interventional Systems, Terumo Medical Products, and Terumo Transfusion Products. The company was founded in 1972 and is based in Somerset, NJ. | Medical Specialties | Human Resources Officer | |
Philip Morris USA, Inc.
Philip Morris USA, Inc. TobaccoConsumer Non-Durables Philip Morris USA, Inc. makes and markets tobacco goods. Its products include cigarette non-tobacco, cigarette tobacco and flavor ingredients. The company was founded by Philip Morris in 1847 and is headquartered in Richmond, VA. | Tobacco | Corporate Officer/Principal | |
University of Basel | College/University | Corporate Officer/Principal | |
Robert Wood Johnson Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
University of Huddersfield | College/University | Undergraduate Degree | |
Tufts Medical Center, Inc.
Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Tufts Medical Center, Inc. owns and operates an academic medical center. It provides healthcare services and programs in the areas of allergy, anesthesiology, bariatric surgery, cancer, cardiology, colon and rectal, clinical nutrition, dentistry, dermatology, ENT/otolaryngology, endocrinology, diabetes and metabolism, gastroenterology, general surgery, geriatrics, hematology/oncology, hyperbaric medicine, infectious diseases, maternity, nephrology, neurology, neurosurgery, and nutrition. The firm also offers services in the areas of obstetrics and gynecology, occupational therapy, ophthalmology, orthopedics, otolaryngology, pain management, palliative care, pathology, pediatrics, physical medicine, physical therapy, plastic surgery, psychiatry, pulmonary, radiation oncology, radiology, rheumatology, speech language pathology and audiology, thoracic and transplant surgery, trauma surgery, urology, vascular surgery, wound healing, and weight and wellness. The company was founded in 1796 and is headquartered in Boston, MA. | Hospital/Nursing Management | Director/Board Member Corporate Officer/Principal | |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal | |
Biogen Canada, Inc. | Corporate Officer/Principal | ||
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
SORRENTO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ARCH BIOPARTNERS INC. | Pharmaceuticals: Major | Director/Board Member | |
Biogen International GmbH
Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
UMass Chan Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Marwood Group LLC
Marwood Group LLC Miscellaneous Commercial ServicesCommercial Services Founded in 2000 by John T. Moore and Edward M. Kennedy, Jr., Marwood Group LLC is a healthcare advisory and financial services firm headquartered in New York City. The firm is a subsidiary of Marwood Group & Co. USA LLC | Miscellaneous Commercial Services | President | |
Mali Health Organizing Project | Director/Board Member | ||
CLEARPOINT NEURO, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Build NYC Resource Corp.
Build NYC Resource Corp. Miscellaneous Commercial ServicesCommercial Services Build NYC Resource Corp. is an economic development agency that assists organizations and exempt facilities in accessing debt through tax-exempt bond financing for real estate capital investments. The non-profit company is based in New York, NY and has subsidiaries in the United States. | Miscellaneous Commercial Services | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Yale College | College/University | Undergraduate Degree Undergraduate Degree | |
PTC Therapeutics GT, Inc.
PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Part of PTC Therapeutics, Inc., PTC Therapeutics GT, Inc. is a company that innovates DNA therapeutics to provide long-term efficacy for patients with debilitating and fatal diseases. The company is based in Lynnfield, MA. The company was founded by Chrystyna Bedrij Stecyk. | Medical Specialties | President Chief Operating Officer | |
AgNovos Healthcare LLC
AgNovos Healthcare LLC Medical SpecialtiesHealth Technology AgNovos Healthcare LLC is a medical technology company that develops new products using regenerative medicine to address bone disease. The company is based in Rockville, MD, where they have their corporate headquarters, manufacturing, research & development, and corporate support services. The company's first product, the Ossure® Local Osteo-Enhancement Procedure Kit, is CE-marked to form new bone in the pelvis and extremities. AgNovos Healthcare was founded in 2012 by James Howe and Tanner Howe, with Tanner Howe serving as the CEO since then. | Medical Specialties | Director/Board Member Director/Board Member | |
PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal |
Statistics
International
United States | 40 |
United Kingdom | 3 |
Switzerland | 3 |
Canada | 3 |
Italy | 2 |
Sectoral
Health Technology | 23 |
Consumer Services | 13 |
Finance | 6 |
Consumer Non-Durables | 3 |
Commercial Services | 3 |
Operational
Director/Board Member | 147 |
Corporate Officer/Principal | 98 |
Independent Dir/Board Member | 45 |
Undergraduate Degree | 23 |
President | 21 |
Most connected contacts
Insiders | |
---|---|
Glenn Steele | 54 |
Jerome Zeldis | 38 |
Michael Schmertzler | 29 |
David Southwell | 19 |
Mark Pykett | 19 |
Dawn Svoronos | 19 |
Emma Reeve | 18 |
Adrian Haigh | 15 |
Mary Smith | 14 |
Alethia Young | 11 |
Jodi Cook | 10 |
Matthew Klein | 10 |
Stuart Peltz | 10 |
Stephanie Okey | 9 |
Anne Marie Conway | 9 |
- Stock Market
- Insiders
- Jeanine Clemente
- Company connections